marine link image
Register now for the Port of the Future Conference • 2 Days, 50 Ports • Houston/Galveston area, TX • April 12–14, 2027

Navios Maritime Containers Adds 10,000 TEU Vessel

June 4, 2018

 Navios Maritime Containers announced that it took delivery of the Navios Unison, a 2010-built, 10,000 TEU containership on May 30, 2018. As previously announced, the vessel was acquired for a price of $50.25 million.

 
The vessel is chartered out at a net rate of $26,663 per day until March 2019. The vessel is expected to generate approximately $6.8 million of EBITDA for the first year, assuming (a) revenue based on contracted time charter rate through the charter expiration date and same rate per open day thereafter and (b) operating expenses in line with the management agreement and normal operations.
 
The acquisition of the vessel was financed with cash on the balance sheet and a $25.0 million term loan facility. The facility has an amortization profile of 9 years, matures in June 2023 and bears interest at LIBOR plus 300 bps per annum.
 
Navios Containers controls 25 vessels, totaling 119,538 TEU, with a current average fleet age of 10.2 years. Navios Maritime Containers Inc. is a growth vehicle dedicated to the container sector of the maritime industry.
 

Logistics News

AAPA Presents 2026 Lighthouse Award to Winners for Port Industry Excellence

AAPA Presents 2026 Lighthouse Award to Winners for Port Industry Excellence

Hapag-Lloyd: Israel Should Review Improved ZIM Offer

Hapag-Lloyd: Israel Should Review Improved ZIM Offer

SSE Picks Montrose Port for 1.4GW Scottish Offshore Wind Farm Ops Base

SSE Picks Montrose Port for 1.4GW Scottish Offshore Wind Farm Ops Base

GTT Marine, Normec Verifavia Announce Emissions Compliance Partnership

GTT Marine, Normec Verifavia Announce Emissions Compliance Partnership

Subscribe for Maritime Logistics Professional E‑News

Ukraine exports to Baltic ports, just like Russia
Alaska Air expects certification of the Boeing 737 MAX 10 by end-September
Denmark's central banks expects a 4% growth in GDP by 2026, driven by the pharmaceutical industry